Pfizer expands hemophilia gene therapy pipeline with $720m Sangamo deal – BioPharma-Reporter.com
BioWorld OnlinePfizer expands hemophilia gene therapy pipeline with $720m Sangamo dealBioPharma-Reporter.comThe agreement sees Pharma giant Pfizer pay Sangamo $70m upfront, but the Californian genome editing firm could receive up to $475m in milestone … Continue reading
